Table 3.
Risk of Bias assessment using the MINORS criteria for each study
| Study | Clearly stated aim | Inclusion of consecutive patients | Prospective collection of data | Endpoint appropriate to the aim of the study | Unbiased assessment of the study endpoint | Follow up period appropriate to the aim of the study | Loss of follow up less than 5% | Prospective calculation of the study size | An adequate control group | Contemporary group | Baseline equivalence of groups | Adequate statistical analysis | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seyler [36] | 2 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 1 | 0 | 2 | 14 |
| Bonutti [8] | 2 | 0 | 0 | 2 | 0 | 2 | 0 | 2 | 2 | 1 | 0 | 2 | 13 |
| Plate [33] | 2 | 1 | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 1 | 0 | 2 | 12 |
| Zengerink [45] | 2 | 0 | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 1 | 0 | 2 | 13 |
| Venkatesh [40] | 2 | 0 | 0 | 2 | 0 | 2 | 1 | 0 | 2 | 1 | 0 | 2 | 12 |
| Woo [42] | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 2 | 11 |
| Murray [30] | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 20 |
| Xu [44] | 2 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 2 | 1 | 0 | 2 | 11 |
| Polat [34] | 2 | 1 | 0 | 2 | 0 | 2 | 0 | 0 | 2 | 1 | 0 | 2 | 12 |